Marcin Kowanetz

31.2k citations
110 papers · 12.9k · 5 hit papers · h-index 46

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 67
    • Colorectal Cancer Treatments and Studies 15
    • CAR-T cell therapy research 15
    • Lung Cancer Research Studies 9
    • Lung Cancer Treatments and Mutations 19

Marcin Kowanetz

107 papers receiving 12.8k citations

Marcin Kowanetz's Hit Papers

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial 2019 · 698 citations
6980+5+10Years since publication50010001.5k2.0k2.5k

Peers

Marcin Kowanetz
Comparison fields: 5 of 117
  • Oncology 8.1k
  • Pulmonary and Respiratory Medicine 3.8k
  • Immunology 2.5k
  • Cancer Research 1.4k
  • Molecular Biology 2.7k
Replace Marisa Dolled‐Filhart with:
Marisa Dolled‐Filhart United States
Genichiro Ishii Japan
Kohei Shitara Japan
Toshihiko Doi Japan
Matteo S. Carlino Australia
Leena Gandhi United States
Shumei Kato United States
Reshma Rangwala United States
Mark Ayers United States
Marcin Kowanetz relative to Marisa Dolled‐Filhart United States Marisa Dolled‐Filhart's profile →
Citations per field
00.5×1.7×
Marisa Dolled‐Filhart · 1×
Citations per year

Countries citing papers authored by Marcin Kowanetz

Since Specialization
Citations

This map shows the geographic impact of Marcin Kowanetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Kowanetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Kowanetz more than expected).

Fields of papers citing papers by Marcin Kowanetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcin Kowanetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Kowanetz. The network helps show where Marcin Kowanetz may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcin Kowanetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcin Kowanetz Line = papers co-authored together Marcin Kowanetz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Hit paper breakdown →
20182686
2
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Hit paper breakdown →
20162139
3
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
20191170
4
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
Hit paper breakdown →
2019698
5
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Hit paper breakdown →
2010512
6 2005497
7 2006456
8 2009394
9 2004277
10 2002195
11 2018170
12 2003168
13 2013157
14 2017153
15 2013139
16 2018138
17 2018115
18 2003108
19 2004104
20 2018102

About Marcin Kowanetz

Marcin Kowanetz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Molecular Biology, having authored 110 papers that have together received 12.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (67 papers), Cancer Genomics and Diagnostics (19 papers), Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (15 papers), CAR-T cell therapy research (15 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Lung Cancer Research Studies (9 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Oncology (8.1k citations), Pulmonary and Respiratory Medicine (3.8k citations), Immunology (2.5k citations), Cancer Research (1.4k citations) and Molecular Biology (2.7k citations). Marcin Kowanetz has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Napoleone Ferrara, Alan Sandler, Federico Cappuzzo, Aristidis Moustakas, Achim Rittmeyer, Carl‐Henrik Heldin, Robert M. Jotte, Delvys Rodríguez‐Abreu, Fabrice Barlési and Daniil Stroyakovskiy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancer Research and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact